Quadrant Capital Group’s Veracyte VCYT Stock Holding History

Quadrant Capital Group’s Portfolio VCYT Stock Details VCYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-298	Closed	-$9.6K	–	2537
2026 Q1	$9.6K	Sell	298 -66	-18%	-$2.44K	﹤0.01%	2198
2025 Q4	$15.3K	Buy	364 +66	+22%	+$2.66K	﹤0.01%	2092
2025 Q3	$10.2K	Buy	+298	New	+$8.55K	﹤0.01%	2153
2025 Q2	–	Sell	-9	Closed	-$267	–	2578
2025 Q1	$267	Hold	9	–	–	﹤0.01%	2701
2024 Q4	$357	Hold	9	–	–	﹤0.01%	2670
2024 Q3	$307	Hold	9	–	–	﹤0.01%	2690
2024 Q2	$196	Hold	9	–	–	﹤0.01%	2664
2024 Q1	$200	Hold	9	–	–	﹤0.01%	2691
2023 Q4	$248	Hold	9	–	–	﹤0.01%	2658
2023 Q3	$201	Hold	9	–	–	﹤0.01%	2647
2023 Q2	$230	Hold	9	–	–	﹤0.01%	2647
2023 Q1	$201	Hold	9	–	–	﹤0.01%	2675
2022 Q4	$214	Hold	9	–	–	﹤0.01%	2694
2022 Q3	$0	Sell	9 -404	-98%	-$9.09K	﹤0.01%	2813
2022 Q2	$8K	Buy	+413	New	+$8.34K	﹤0.01%	1802

Other funds holding VCYT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Quadrant Capital Group's VCYT Position: Q2 2026 in Review

Quadrant Capital Group sold out of Veracyte (VCYT) in Q2 2026, closing a stake of 298 shares — an estimated $9.6K sold.

Quadrant Capital Group first reported a position in VCYT in Q2 2022 and held it in 15 quarters. The position peaked at $15.3K in Q4 2025. 370 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

Quadrant Capital Group reported no remaining Veracyte position as of Q2 2026 after selling out during the quarter.
Quadrant Capital Group sold 298 Veracyte shares in Q2 2026, an estimated $9.6K.
Quadrant Capital Group first reported a position in Veracyte in Q2 2022 and held it in 15 quarters.
Quadrant Capital Group's Veracyte position peaked at $15.3K in Q4 2025.
370 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on Quadrant Capital Group's 13F filing for Q2 2026, filed 14 Aug 2026.